NeurAxis, Inc.
NRXS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $3 | $3 |
| % Growth | 9.2% | -8.4% | -1.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 86.5% | 87.7% | 88.9% | 82.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $9 | $8 | $5 | $5 |
| SG&A Expenses | $9 | $9 | $6 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $9 | $6 | $5 |
| Operating Income | -$7 | -$7 | -$3 | -$3 |
| % Margin | -266.5% | -270.9% | -125.6% | -109.1% |
| Other Income/Exp. Net | -$1 | -$8 | -$1 | -$0 |
| Pre-Tax Income | -$8 | -$15 | -$5 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$15 | -$5 | -$3 |
| % Margin | -306.8% | -594.6% | -178% | -111.3% |
| EPS | -1.22 | -2.32 | -0.57 | -0.62 |
| % Growth | 47.4% | -307% | 8.1% | – |
| EPS Diluted | -1.22 | -2.32 | -0.78 | -0.62 |
| Weighted Avg Shares Out | 7 | 6 | 8 | 5 |
| Weighted Avg Shares Out Dil | 7 | 6 | 8 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$0 | -$2 | $0 |
| Interest Expense | $0 | $5 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$9 | -$4 | -$3 |
| % Margin | -294.2% | -375.1% | -161.1% | -108.6% |